Building on the involvement of mitochondrial-dysfunction in the etiology and treatment of BD we have recently designed a novel mouse model of BD-like behavior and neurochemistry [6] achieved by chronic treatment with a never used before low-dose rotenone, a mitochondrial complex-I (CoI) inhibitor, which induces mild mitochondrial-dysfunction. The gene discussed is MT-CO1; the disease is Behcet disease.